LSUMC MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM

我们的社区需要改善对癌症患者的护理 疾病，特别是我们的少数民族人口。我们的长期目标是 带来癌症控制和最先进的癌症的优势 在我们的目标人群中，治疗的患者数量要多得多。 为了提高患者，特别是少数族裔患者的收入， 我们需要大幅扩大我们的支持结构。我们有一个很强的 在癌症治疗方面的多学科努力的历史由许多 医疗保健专业人员，这可能会降低发病率和 死亡率以及目标人群中的癌症事件。 不幸的是，我们缺乏所需的支持人员 扩大我们的工作。这项提议旨在大幅增加数据 管理人员和支持结构需要提供充足的 扩大我们的临床癌症研究的机会。我们的多中心 方法允许我们访问三个最大的城市区域中的两个 少数民族最集中的地方。这一点很重要，因为少数族裔 NCI癌症研究方案的收益一直很低。通过注册 更多这些服务不足的人群参加国家试验，希望 对这一群体的整体护理可以得到改善。这是一个雄心勃勃的 使用集中式数据管理系统的多中心方法 招募和跟踪患者。我们机构的流行病学家已经 与许多癌症的发病率相比，确定了过高的死亡率。 超额死亡率在中国的少数民族中尤为突出。 州政府。该州内部正在努力确定最高 死亡率与发病率相比，这些癌症的主要因素 似乎延误了诊断。获得护理本身并不是一个因素。 由于路易斯安那州在各州中是独一无二的，它拥有全州范围的、州立的 为贫困人口提供护理的制度。尽管有这个系统，患者似乎并没有 及时提出诊断。可能会影响的因素 患者延误诊断是因为缺乏关于癌症筛查的信息。 路易斯安那州立大学参加了几个合作试验小组，并已证明 承诺将所有调查员纳入一个组织 具有集中数据管理的结构，从而消除了重复。 简化这一行动将使更多人能够接触到新的人口 在该州南部。不断增加的癌症登记人数 治疗和对照试验应在促进 筛查和更早获得照顾该州所有公民的机会， 尤其是少数民族人口。

Our community is in need of improved care for patients with malignant diseases, especially our minority population. Our long-term goals are to bring the advantages of cancer control and state-of-the-art cancer treatment to a much larger number of patients in our target population. In order to enhance the accrual of patients, especially minority patients, we need to dramatically expand our support structure. We have a strong history of a multi-disciplinary effort in cancer care by a large number of health care professionals, which can potentially reduce the morbidity and mortality as well as the cancer incidents in this targeted population. Unfortunately, we have had a dearth of support personnel required to expand our work. This proposal aims to dramatically increase the Data Management personnel and support structure needed to provide ample opportunity to expand our clinical cancer research. Our multi-center approach allows us access to two of the three largest urban areas with the highest concentration of minorities. This is important since minority accrual to NCI cancer research protocols has been so poor. By enrolling more of this underserved population to national trials, it is hoped that the overall care of this population can be improved. This is an ambitious multi-center approach, using a centralized data management system, to recruit and follow-up patients. Epidemiologists at our institution have identified excess mortality compared to the incidence of many cancers. Excess mortality is especially found among the minority population of the state. Efforts are underway within the state to determine the high mortality compared to incidence for these cancers but the main factor appears to be delay in diagnosis. Access to care, per se, is not a factor since Louisiana is unique among states in having a state-wide, state-run system for indigent care. Despite this system, patients do not appear to present for diagnosis in a timely fashion. Factors which could effect patient delay in diagnosis are lack of information about cancer screening. LSU has participated in several cooperative trial groups and has a proven commitment to enrollment of all investigators into one organizational structure with centralized data management, thus eliminating duplication. Streamlining this operation will allow greater access to new populations in the southern part of the state. Increasing enrollments in cancer treatment and control trials should have an enhanced effect in promoting screening and earlier access to care for all the citizens of the state, especially the minority populations.